Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-004893
Filing Date
2019-02-26
Accepted
2019-02-26 17:18:17
Documents
2
Period of Report
2019-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9898
2 EX-99.1 DOCUMENT attachment1.htm EX-99.1 479
  Complete submission text file 0000899243-19-004893.txt   13127
Mailing Address C/O KOS PHARMACEUTICALS, INC. 1001 BRICKELL BAY DRIVE, 25TH FLOOR MIAMI FL 33131
Business Address
Ferro Kevin (Reporting) CIK: 0001299331 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35405 | Film No.: 19634541

Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Issuer) CIK: 0001461993 (see all company filings)

EIN.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VATERA HOLDINGS LLC 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022
Business Address C/O VATERA HOLDINGS LLC 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022 212 590 2950
Vatera Healthcare Partners LLC (Reporting) CIK: 0001722413 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35405 | Film No.: 19634539

Mailing Address 400 ROYAL PALM WAY SUITE 212 PALM BEACH FL 33480
Business Address 400 ROYAL PALM WAY SUITE 212 PALM BEACH FL 33480 561 300 4860
Vatera Capital Management LLC (Reporting) CIK: 0001764047 (see all company filings)

State of Incorp.: CT | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35405 | Film No.: 19634540